ZYBT

About Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT) Stock

Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT) closed the 2026-09-18 session at $1.37, up 0.00% versus the previous close (+0.00). The stock opened at $1.35 and traded between $1.35 and $1.39 during that session. Session trading volume was 22K shares. The volume-weighted average price (VWAP) is $1.37.

Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry and other vaccines.

Zhengye Biotechnology Holding Limited Class A Ordinary Shares has a market capitalization of $64.9 million. ZYBT is listed on the XNAS exchange. The company employs approximately 269 people. The recorded listing date is 2025-01-07.

On this page you can find market ZYBT stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors.